期刊文献+

血清降钙素水平检测在肺部感染用药指导及疗效评价中的应用分析 被引量:4

Application of PCT Levels in the Efficacy Evaluation and Medication Guidance for Pulmonary Infection
下载PDF
导出
摘要 目的探讨血清降钙素水平检测在肺部感染用药指导和疗效评价中的应用价值。方法按照数字表随机分组法,将我院收治的73例肺部感染患者分为两组。对照组依据临床医生经验使用抗菌药物,而观察组则根据血清PCT水平指导抗菌药应用。比较两组抗菌药物使用情况及临床疗效,比较不同疗效患者之间的血清PCT水平。结果观察组抗生素使用时间、使用比例及临床总有效率均优于对照组,组间对比,差异有统计学意义(P<0.05)。痊愈患者的血清PCT水平低于其他疗效患者(P<0.05)。结论血清PCT水平可有效指导肺部感染患者的临床用药,可作为临床疗效的直观评价指标。 Objective To explore the application of PCT levels in the efficacy evaluation and medication guidance for pulmonary infection.Methods According to the digital table random grouping method, 73 cases of pulmonary infection were divided into two groups. The control group was treated with antibiotics according to the clinician's experience, the observation group based on serum PCT level to guide the application of antibiotics. The use of antibacterials and clinical efficacy were compared between the two groups, serum PCT levels were compared among patients with different efficacy. Results The observation group was significantly better than the control group in the antimicrobial use time, antimicrobial use ratio and total effective rate, the difference was statistically significant (P〈0.05). The cured patients were significantly lower than other patients in serum calcitonin levels, the difference was statistically significant (P〈0.05). Conclusion Serum PCT levels can be used as visual indicators in the efficacy evaluation and medication guidance for pulmonary infection.
作者 陈艺慧 张海涛 黄玉蓉 CHEN Yihui ZHANG Haitao HUANG Yurong(Department of Respiratory Medicine, Xinjiang Production and Construction Corps Hospital, Urumqi Xinjiang 832002, Chin)
出处 《中国继续医学教育》 2017年第17期163-165,共3页 China Continuing Medical Education
关键词 血清降钙素 肺部感染 用药指导 疗效评价 应用 serum calcitonin pulmonary infection medication guidance efficacy evaluation application
  • 相关文献

参考文献8

二级参考文献74

  • 1卯建,赵滢,代蓉蓉,唐睿珠,段勇.降钙素原、超敏C-反应蛋白和淀粉样蛋白检测在细菌性感染诊断中的应用价值[J].昆明医科大学学报,2013,34(7):79-82. 被引量:12
  • 2张宗新.降钙素原在细菌感染性疾病诊断中的应用探讨[J].检验医学,2006,21(2):117-119. 被引量:59
  • 3卫生部抗生素临床药理基地.抗菌药物临床研究指导原则.中国临床药理学杂志,1987,2:189-191.
  • 4Marshall JC, Reinhart K, International Sepsis Forum. Biomarkers of sepsis[J]. Crit Care Med, 2009, 37(7):2290-2298.
  • 5Simon L, Gauvin F, Amre DK, et al. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: A systematic review and meta-analysis[J]. Clin Infect Dis, 2004, 39(2): 206-217.
  • 6Tang BM, Eslick GD, Craig JC, et al. Accuracy of procalci tonin for sepsis diagnosis in critically ill patients: systematic review and metaanalysis [ J ]. Lancet Infect Dis, 2007,7 (3) :210-227.
  • 7Christ-Crain M, Muller B. Procalcitonin in bacterial infections-hype,hope more or less? [J]. Swiss Med Wkly, 2005, 135(31-32) : 451-460.
  • 8American Thoracic Society, Infectious Disease Society of A merica. Guidelines for the management of adults with hospital-acquired, ventilator associated, and healthcare-associated pneumonia[J]. Am J Respir Crit Care Med, 2005, 171(4) : 388-416.
  • 9Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008[J]. Crit Care Med, 2008,36 (1) :296-327.
  • 10Schuetz P,Christ-Crain M,Thomann R,et al. Effect of procaleitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infeetions: the ProHOSP randomized controlled trial [J]. JAMA, 2009, 302 ( 10 ) : 1059 1066.

共引文献73

同被引文献28

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部